About Starcaps PDF Print

Developed by: 

 

 Balanced Health Products, Inc.

 

Use:

 

Dietary Supplement

 

Background:

 

In December, the FDA issued an immediate recall of Starcaps because the supplement was found to contain an undeclared drug ingredient, Bumetanide. Bumetanide, which is not listed on the label, is a prescription only diuretic indicated for the treatment of edema associated with congestive heart failure, hepatic, and renal disease including nephrotic syndrome. Potential risks associated with the use of Bumetanide include:

 

  • Serious fluid and electrolyte loss
  • Elevation in uric acid concentrations
  • Drug interactions with digoxin and lithium may lead to an increased risk of toxicity.
  • Increased risk of hypotension(low blood pressure)
  • Fainting
  • Resultant injury if you are already taking an antihypertension medication

 

Action Summary:

 

The FDA is advising consumers who purchased Starcaps Dietary Supplement Capsules with undeclared Bumetanide with lot numbers:

  • 12/2009- 82866
  • 12/2010 -83801
to immediately discontinue the use of the recalled product and return it to Balanced Health Products at the address located on the product's label.
 
© 2008 leflaw.com design by tracy feldman